Genomic Health investor Baker Brothers increases ownership to 20.2%

By Lisa Kerner

Charlotte, N.C., Aug. 17 - Genomic Health, Inc. investors Julian C. Baker and Felix J. Baker bought 187,486 shares of the company's stock between Aug. 10 and Aug. 17 priced from $19.50 to $19.99 each, according to a schedule 13D/A filed with the Securities and Exchange Commission on Monday.

Baker Brothers Investments, LP beneficially owns 5,771,072 shares, or 20.2%, of the Redwood City, Calif., biotechnology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.